Rina Ando

548 total citations
33 papers, 249 citations indexed

About

Rina Ando is a scholar working on Neurology, Molecular Biology and Epidemiology. According to data from OpenAlex, Rina Ando has authored 33 papers receiving a total of 249 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Neurology, 9 papers in Molecular Biology and 5 papers in Epidemiology. Recurrent topics in Rina Ando's work include Parkinson's Disease Mechanisms and Treatments (13 papers), Neurological disorders and treatments (6 papers) and Peripheral Neuropathies and Disorders (5 papers). Rina Ando is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (13 papers), Neurological disorders and treatments (6 papers) and Peripheral Neuropathies and Disorders (5 papers). Rina Ando collaborates with scholars based in Japan and United States. Rina Ando's co-authors include Masahiro Nagai, Hayato Yabe, Satoshi Tada, Masahiro Nomoto, Yuki Yamanishi, Noriko Nishikawa, Hirotaka Iwaki, Yuki Kagawa, Masatomo Kuwabara and Izumi Imaoka and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the Neurological Sciences and Journal of Neuroimmunology.

In The Last Decade

Rina Ando

31 papers receiving 246 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rina Ando Japan 10 115 53 41 35 34 33 249
Daniëlle Hernalsteen Belgium 8 53 0.5× 41 0.8× 19 0.5× 58 1.7× 36 1.1× 16 276
Jinze Wu China 9 69 0.6× 22 0.4× 24 0.6× 104 3.0× 30 0.9× 12 310
Lun Luo China 11 123 1.1× 79 1.5× 84 2.0× 128 3.7× 19 0.6× 52 453
Eleonora Mauri Italy 7 80 0.7× 28 0.5× 13 0.3× 76 2.2× 25 0.7× 22 332
Barbara Galbardi Italy 9 92 0.8× 17 0.3× 18 0.4× 54 1.5× 8 0.2× 17 255
Hugh Harrington Ireland 11 170 1.5× 46 0.9× 21 0.5× 66 1.9× 19 0.6× 20 332
Gaëtan Poulen France 9 152 1.3× 72 1.4× 5 0.1× 37 1.1× 44 1.3× 30 326
You Jeong Park United States 11 34 0.3× 14 0.3× 34 0.8× 98 2.8× 58 1.7× 19 277
M. Yu. Martynov Russia 9 95 0.8× 17 0.3× 22 0.5× 56 1.6× 78 2.3× 63 263

Countries citing papers authored by Rina Ando

Since Specialization
Citations

This map shows the geographic impact of Rina Ando's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rina Ando with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rina Ando more than expected).

Fields of papers citing papers by Rina Ando

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rina Ando. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rina Ando. The network helps show where Rina Ando may publish in the future.

Co-authorship network of co-authors of Rina Ando

This figure shows the co-authorship network connecting the top 25 collaborators of Rina Ando. A scholar is included among the top collaborators of Rina Ando based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rina Ando. Rina Ando is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Shuang, Yuko Ito, Yuki Yamanishi, et al.. (2025). Association of Enterococcus faecalis and tyrosine decarboxylase gene levels with levodopa pharmacokinetics in Parkinson’s disease. npj Parkinson s Disease. 11(1). 49–49. 3 indexed citations
2.
Ito, Yuko, Yuki Yamanishi, Satoshi Tada, et al.. (2024). Optimization of oral entacapone administration in patients undergoing levodopa–carbidopa intestinal gel treatment. Journal of the Neurological Sciences. 457. 122901–122901. 1 indexed citations
3.
Ito, Yuko, et al.. (2024). Blepharoptosis As an Early Manifestation of Neuronal Intranuclear Inclusion Disease. Internal Medicine. 63(8). 1163–1166.
4.
Nagai, Masahiro, et al.. (2023). Differing Patterns of Diurnal Variation and Impact of Antacids on Levodopa Pharmacokinetics in Patients with Parkinson's Disease. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 54(1). 3–8. 1 indexed citations
5.
Hosokawa, Yuko, et al.. (2022). Clinical use of CSF neopterin levels in CNS demyelinating diseases. Journal of the Neurological Sciences. 441. 120385–120385. 5 indexed citations
6.
Hosokawa, Yuko, Akira Yoshida, Yuki Yamanishi, et al.. (2021). Fasting state is one of the factors associated with plasma levodopa fluctuations during levodopa‒carbidopa intestinal gel treatment. Parkinsonism & Related Disorders. 91. 55–58. 6 indexed citations
7.
Choudhury, Mohammed E., Ryo Utsunomiya, Hajime Yano, et al.. (2021). Insomnia and depressive behavior of MyD88-deficient mice: Relationships with altered microglial functions. Journal of Neuroimmunology. 363. 577794–577794. 16 indexed citations
8.
Yabe, Hayato, et al.. (2020). Relapse of neuromyelitis optica with occipital neuralgia and elevated CSF neopterin. Neurology and Clinical Neuroscience. 8(4). 209–211. 2 indexed citations
9.
Yabe, Hayato, et al.. (2020). Three cases of rheumatoid meningitis with elevated CSF neopterin levels. Journal of Neuroimmunology. 348. 577396–577396. 6 indexed citations
10.
Iwaki, Hirotaka, Rina Ando, Satoshi Tada, et al.. (2020). A double-blind, randomized controlled trial of duloxetine for pain in Parkinson's disease. Journal of the Neurological Sciences. 414. 116833–116833. 14 indexed citations
11.
Yamanishi, Yuki, Satoshi Tada, Rina Ando, et al.. (2019). A case of ADEM-like presentation with anti-MOG antibody following tumefactive demyelinating lesion. Multiple Sclerosis and Related Disorders. 31. 62–64. 11 indexed citations
12.
Yamanishi, Yuki, et al.. (2019). Acromioclavicular joint arthritis as the first manifestation of Austrian syndrome. Journal of Infection and Chemotherapy. 26(1). 124–127. 1 indexed citations
13.
Yamanishi, Yuki, Satoshi Tada, Rina Ando, et al.. (2019). Repetitive brainstem lesions in mitochondrial DNA 11778G>A mutation of Leber hereditary optic neuropathy. eNeurologicalSci. 14. 74–76. 2 indexed citations
14.
Yamaguchi, Tetsuo, Rina Ando, Tetsuya Matsumoto, Yoshikazu Ishii, & Kazuhiro Tateda. (2019). <p>Association between cell growth and vancomycin resistance in clinical community-associated methicillin-resistant <em>Staphylococcus aureus</em></p>. Infection and Drug Resistance. Volume 12. 2379–2390. 6 indexed citations
15.
Nomoto, Masahiro, Masahiro Nagai, Noriko Nishikawa, et al.. (2018). Pharmacokinetics and safety/efficacy of levodopa pro-drug ONO-2160/carbidopa for Parkinson's disease. eNeurologicalSci. 13. 8–13. 12 indexed citations
16.
Ando, Rina, Mohammed E. Choudhury, Yuki Yamanishi, et al.. (2018). Modafinil alleviates levodopa-induced excessive nighttime sleepiness and restores monoaminergic systems in a nocturnal animal model of Parkinson's disease. Journal of Pharmacological Sciences. 136(4). 266–271. 14 indexed citations
17.
Ando, Rina, Hirotaka Iwaki, Hayato Yabe, et al.. (2017). <b>Relationship between Serious Traffic Accidents and Medications in Patients with Parkinson's Disease </b>. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 48(5). 167–171. 1 indexed citations
18.
Tada, Satoshi, Rina Ando, Hirotaka Iwaki, et al.. (2017). DAT SPECT may have diagnostic value in prodromal SCA2 patients with parkinsonism. Parkinsonism & Related Disorders. 44. 137–141. 6 indexed citations
19.
Iwaki, Hirotaka, Rina Ando, Satoshi Tada, et al.. (2017). One year safety and efficacy of inosine to increase the serum urate level for patients with Parkinson's disease in Japan. Journal of the Neurological Sciences. 383. 75–78. 21 indexed citations
20.
Okada, Masahiro, Taro Shimono, Rina Ando, et al.. (2009). Adrenal masses: the value of additional fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in differentiating between benign and malignant lesions. Annals of Nuclear Medicine. 23(4). 349–354. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniëlle Hernalsteen Breakdown of academic impact, for papers by Jinze Wu Breakdown of academic impact, for papers by Lun Luo Breakdown of academic impact, for papers by Eleonora Mauri Breakdown of academic impact, for papers by Barbara Galbardi Breakdown of academic impact, for papers by Hugh Harrington Breakdown of academic impact, for papers by Gaëtan Poulen Breakdown of academic impact, for papers by You Jeong Park Breakdown of academic impact, for papers by M. Yu. Martynov
Rankless by CCL
2026